HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean Michel Cayuela Selected Research

Jean Michel Cayuela Research Topics

Disease

5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2014 - 01/2007
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021 - 01/2019
1Philadelphia Chromosome
12/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2019
1Eosinophilia
05/2014
1Bronchiolitis Obliterans Syndrome
05/2014
1Drug Hypersensitivity Syndrome
05/2014
1Pdgfra-Associated Chronic Eosinophilic Leukemia
09/2013
1Blast Crisis (Blast Phase)
06/2011
1T-Cell Lymphoma (Lymphoma, T Cell)
05/2008
1Congenital Diaphragmatic Hernias
01/2005

Drug/Important Bio-Agent (IBA)

5Imatinib Mesylate (Gleevec)FDA Link
02/2014 - 01/2007
3Tyrosine Kinase InhibitorsIBA
02/2014 - 06/2011
2Biological ProductsIBA
01/2019 - 05/2014
1ponatinibIBA
12/2021
1asciminibIBA
12/2021
1Protein Tyrosine PhosphatasesIBA
01/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2019
1EpitopesIBA
05/2014
1Interleukin-17 (Interleukin 17)IBA
05/2014
1Dasatinib (BMS 354825)FDA Link
11/2012
1KIR ReceptorsIBA
11/2012
1Cytarabine (Cytosar-U)FDA LinkGeneric
06/2011
1Daunorubicin (Cerubidine)FDA LinkGeneric
06/2011
1Endothelin Receptors (Endothelin Receptor)IBA
01/2005

Therapy/Procedure

2Therapeutics
02/2014 - 11/2012
1Aftercare (After-Treatment)
05/2008